What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Acne
His primary scientific interests are in Acne, Internal medicine, Dermatology, Surgery and Antibiotics.
Particularly relevant to Isotretinoin is his body of work in Acne.
His Internal medicine research integrates issues from Gastroenterology and Endocrinology.
His studies in Dermatology integrate themes in fields like Prospective cohort study, Clinical trial and MEDLINE.
He interconnects Guideline and Incidence in the investigation of issues within Surgery.
His work carried out in the field of Antibiotics brings together such families of science as Propionibacterium acnes and Cumulative dose.
His most cited work include:
- Management of Acne: A Report From a Global Alliance to Improve Outcomes in Acne (636 citations)
- Activation of Toll-Like Receptor 2 in Acne Triggers Inflammatory Cytokine Responses (444 citations)
- A clinical evaluation of acne scarring and its incidence. (378 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Acne, Dermatology, Internal medicine, Endocrinology and Excretion.
William J. Cunliffe has included themes like Antibiotics and Surgery, Chemotherapy in his Acne study.
His Dermatology study incorporates themes from Clinical trial, Disease, Etiology and MEDLINE.
His Internal medicine research incorporates elements of Gastroenterology, Minocycline and Placebo.
His Endocrinology research is mostly focused on the topic Triglyceride.
His work in Excretion is not limited to one particular discipline; it also encompasses Lipid composition.
He most often published in these fields:
- Acne (54.15%)
- Dermatology (36.31%)
- Internal medicine (21.23%)
What were the highlights of his more recent work (between 1999-2014)?
- Acne (54.15%)
- Dermatology (36.31%)
- Internal medicine (21.23%)
In recent papers he was focusing on the following fields of study:
His main research concerns Acne, Dermatology, Internal medicine, Propionibacterium acnes and Endocrinology.
As a part of the same scientific study, William J. Cunliffe usually deals with the Acne, concentrating on Antibacterial agent and frequently concerns with Clindamycin.
His study in Dermatology is interdisciplinary in nature, drawing from both Retinoid, Clinical trial, Biopsy and Etiology.
His study on Excretion is often connected to Melanocortin 3 receptor as part of broader study in Internal medicine.
His biological study spans a wide range of topics, including Inflammation, Immunology, Erythromycin, Microbiology and Antibiotic resistance.
His study in the field of Sebaceous gland also crosses realms of Melanocortin 5 receptor.
Between 1999 and 2014, his most popular works were:
- Management of Acne: A Report From a Global Alliance to Improve Outcomes in Acne (636 citations)
- Activation of Toll-Like Receptor 2 in Acne Triggers Inflammatory Cytokine Responses (444 citations)
- Inflammatory events are involved in acne lesion initiation. (314 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Disease
His primary areas of investigation include Acne, Dermatology, Propionibacterium acnes, Pathology and Internal medicine.
The concepts of his Acne study are interwoven with issues in Surgery, Sebaceous gland, Pharmacology, Chronic inflammatory disease and Severe inflammation.
The Dermatology study combines topics in areas such as Therapeutic strategy and Effective treatment.
His studies deal with areas such as Clindamycin, Antibiotics and Cytokine, Immunology as well as Propionibacterium acnes.
William J. Cunliffe works mostly in the field of Pathology, limiting it down to concerns involving Inflammation and, occasionally, Knockout mouse and Interleukin 18.
His research in Internal medicine intersects with topics in Gastroenterology, Endocrinology and Seborrhoeic dermatitis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
